In a clinical trial , participants who took Wegovy injection combined with lifestyle changes lost an average of 15% of their body weight by the end of the 68-week trial
When carnitine availability is adequate, this process runs efficiently
In addition, wide-spread marketing of the weight-loss benefits of these drugs has spurred media attention highlighting differences in use and access between over-resourced and under-resourced populations. According to an Axios report, more than 2% of the US population is currently taking GLP-1s for a variety of reasons, resulting in almost a 600% jump in the use of this medication class since 2019
Heres what patients at Lite Medical should know
Semaglutide stands out for its well-established track record in glycemic control and substantial weight loss, while Tirzepatide introduces a novel dual-action approach that holds promise for comprehensive metabolic improvements
And insurance coverage for weight management medications remains inconsistent